Provided by Tiger Trade Technology Pte. Ltd.

Bluejay Diagnostics Inc

0.9109
-0.0284-3.02%
Post-market: 0.91090.00000.00%19:43 EDT
Volume:120.30K
Turnover:110.77K
Market Cap:4.07M
PE:-0.14
High:0.9475
Open:0.9277
Low:0.9000
Close:0.9393
52wk High:16.68
52wk Low:0.8300
Shares:4.47M
Float Shares:4.12M
Volume Ratio:0.40
T/O Rate:2.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6477
EPS(LYR):-15.2513
ROE:-98.89%
ROA:-51.08%
PB:0.43
PE(LYR):-0.06

Loading ...

Bluejay Diagnostics prices USD 8.5 million at-the-market private placement of shares, warrants

Reuters
·
Jun 09

Bluejay Diagnostics Announces Closing of up to $23.7 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Jun 06

Press Release: Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Dow Jones
·
Jun 06

Bluejay Diagnostics prices USD 8.5 million at-the-market private placement of shares, warrants

Reuters
·
Jun 03

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Jun 03

Press Release: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dow Jones
·
Jun 03

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?

TIPRANKS
·
Jun 02

Top Premarket Gainers

MT Newswires Live
·
Jun 02

Bluejay Diagnostics partners with Argonaut Manufacturing Services to advance Symphony platform

Reuters
·
Jun 02

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

THOMSON REUTERS
·
Jun 02

Bluejay Diagnostics director Svetlana Dey acquires $25,000 common shares

Reuters
·
May 19

Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY

Benzinga Earnings
·
May 08

Bluejay Diagnostics Q1 FY26 net loss unchanged at $1.9 million

Reuters
·
May 08

Bluejay Diagnostics Q1 Net Income USD -1.9 Million

THOMSON REUTERS
·
May 08

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

GlobeNewswire
·
May 08

Bluejay Diagnostics announces annual shareholder meeting

Reuters
·
Apr 21

Bluejay Nears Completion of Pivotal SYMON-II Sepsis Trial

TIPRANKS
·
Apr 07

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

GlobeNewswire
·
Apr 07

Bluejay Diagnostics sells 62,500 shares in private placement for USD 125,000

Reuters
·
Mar 18

Bluejay Diagnostics’ Symphony IL-6 sepsis study accepted for SAEM annual meeting presentation

Reuters
·
Mar 12